156 related articles for article (PubMed ID: 1309703)
1. Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.
Atkinson RA; Pelton JT
FEBS Lett; 1992 Jan; 296(1):1-6. PubMed ID: 1309703
[TBL] [Abstract][Full Text] [Related]
2. A conformational study by 1H NMR of a cyclic pentapeptide antagonist of endothelin.
Coles M; Sowemimo V; Scanlon D; Munro SL; Craik DJ
J Med Chem; 1993 Sep; 36(18):2658-65. PubMed ID: 8410978
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.
Lin M; Chan MF; Balaji VN; Castillo RS; Larive CK
Int J Pept Protein Res; 1996 Sep; 48(3):229-39. PubMed ID: 8897090
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and solution conformation of c(D-Trp-D-Cys(SO3-Na+)-Pro-D-Val-Leu), a potent endothelin-A receptor antagonist.
Bogusky MJ; Brady SF; Sisko JT; Nutt RF; Smith GM
Int J Pept Protein Res; 1993 Aug; 42(2):194-203. PubMed ID: 8407113
[TBL] [Abstract][Full Text] [Related]
5. Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH.
Gürsoy RN; Jois DS; Siahaan TJ
J Pept Res; 1999 Apr; 53(4):422-31. PubMed ID: 10406220
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of human endothelin receptors ETA and ETB identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu).
Becker A; Haendler B; Hechler U; Schleuning WD
Eur J Biochem; 1994 May; 221(3):951-8. PubMed ID: 8181477
[TBL] [Abstract][Full Text] [Related]
7. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
Liu ZP; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
[TBL] [Abstract][Full Text] [Related]
8. Solution conformation of a cyclic pentapeptide endothelin antagonist. Comparison of structures obtained from constrained dynamics and conformational search.
Krystek SR; Bassolino DA; Bruccoleri RE; Hunt JT; Porubcan MA; Wandler CF; Andersen NH
FEBS Lett; 1992 Mar; 299(3):255-61. PubMed ID: 1544503
[TBL] [Abstract][Full Text] [Related]
9. Solvent effects on the conformation of cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-). An NMR spectroscopy and molecular modeling study.
Gonnella NC; Zhang X; Jin Y; Prakash O; Paris CG; Kolossváry I; Guida WC; Bohacek RS; Vlattas I; Sytwu T
Int J Pept Protein Res; 1994 May; 43(5):454-62. PubMed ID: 8070969
[TBL] [Abstract][Full Text] [Related]
10. Competitive and non competitive interactions of BQ-123 with endothelin ETA receptors.
Vigne P; Breittmayer JP; Frelin C
Eur J Pharmacol; 1993 May; 245(3):229-32. PubMed ID: 8335061
[TBL] [Abstract][Full Text] [Related]
11. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
Jois DS; Easwaran KR; Bednarek M; Blout ER
Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of type I and type II beta-turn mixtures. Circular dichroism, NMR and molecular dynamics studies.
Perczel A; Hollósi M; Sándor P; Fasman GD
Int J Pept Protein Res; 1993 Mar; 41(3):223-36. PubMed ID: 8463046
[TBL] [Abstract][Full Text] [Related]
13. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
Nambi P; Wu HL; Pullen M; Aiyar N; Bryan H; Elliott J
Mol Pharmacol; 1992 Aug; 42(2):336-9. PubMed ID: 1325032
[TBL] [Abstract][Full Text] [Related]
14. Location of alkali metal binding sites in endothelin A selective receptor antagonists, cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) and cyclo(D-Trp-D-Asp-Pro-D-Ile-Leu), from multistep collisionally activated decompositions.
Ngoka LC; Gross ML
J Mass Spectrom; 2000 Feb; 35(2):265-76. PubMed ID: 10679990
[TBL] [Abstract][Full Text] [Related]
15. Rediscovering an endothelin antagonist (BQ-123): a self-deconvoluting cyclic pentapeptide library.
Spatola AF; Crozet Y
J Med Chem; 1996 Sep; 39(19):3842-6. PubMed ID: 8809172
[TBL] [Abstract][Full Text] [Related]
16. Conformations of cyclic pentapeptide endothelin receptor antagonists.
Bean JW; Peishoff CE; Kopple KD
Int J Pept Protein Res; 1994 Sep; 44(3):223-32. PubMed ID: 7822098
[TBL] [Abstract][Full Text] [Related]
17. Cyclic cholecystokinin-analog pentapeptide cyclo (Asp-Trp-Met-Asp-Phe): an unexpected solution conformation.
Weisshoff H; Wieprecht T; Henklein P; Antz C; Mügge C
Biochem Biophys Res Commun; 1995 Aug; 213(2):506-12. PubMed ID: 7646505
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the structures of the endothelin A receptor antagonists BQ123 and N-methyl leucine BQ123 with the crystal structure of the C-terminal tail of endothelin-1.
Peishoff CE; Janes RW; Wallace BA
FEBS Lett; 1995 Nov; 374(3):379-83. PubMed ID: 7589575
[TBL] [Abstract][Full Text] [Related]
19. Ion binding of cyclolinopeptide A: an NMR and CD conformational study.
Tancredi T; Benedetti E; Grimaldi M; Pedone C; Rossi F; Saviano M; Temussi PA; Zanotti G
Biopolymers; 1991 May; 31(6):761-7. PubMed ID: 1932572
[TBL] [Abstract][Full Text] [Related]
20. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.
Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM
Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
